Petr Widimský

Q: What Schools Are Affiliated With Petr Widimský

Petr Widimský is affiliated with the following schools: Medical University of Vienna, Charles University

Petr Widimský's AcademicInfluence.com Rankings

Petr Widimský

Philosophy

#7861

World Rank

#11133

Historical Rank

Logic

#4896

World Rank

#6232

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Petr Widimský's Degrees

Doctorate Medicine Charles University
PhD Cardiology Charles University

Why Is Petr Widimský Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Petr Widimský's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2012) (7528)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). (2018) (6316)
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (3077)
Universal definition of myocardial infarction. (2015) (2234)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (2017) (1499)
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial (2011) (1498)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invit (2007) (911)
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. (2005) (827)
Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. (2003) (819)
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2018) (811)
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial (2010) (808)
Early versus delayed invasive intervention in acute coronary syndromes. (2009) (781)
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. (2012) (718)
Effect of platelet inhibition with cangrelor during PCI on ischemic events. (2013) (705)
[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.] (2018) (669)
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries (2009) (640)
Intravenous platelet blockade with cangrelor during PCI. (2009) (590)
Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. (2000) (567)
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. (2010) (549)
Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. (2013) (541)
Randomized trial of primary PCI with or without routine manual thrombectomy. (2015) (520)
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the Europe (2010) (520)
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial (2017) (464)
Facilitated PCI in patients with ST-elevation myocardial infarction. (2008) (456)
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. (2011) (364)
Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. (2008) (327)
Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. (2014) (293)
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial (2000) (252)
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. (2013) (252)
One-Year Coronary Bypass Graft Patency: A Randomized Comparison Between Off-Pump and On-Pump Surgery Angiographic Results of the PRAGUE-4 Trial (2004) (250)
Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. (2019) (249)
Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. (2009) (228)
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. (2020) (224)
Off-pump versus on-pump coronary surgery: final results from a prospective randomized study PRAGUE-4. (2004) (204)
[Guidelines for cardiac pacing and cardiac resynchronization therapy]. (2008) (199)
Ticagrelor in Patients with Stable Coronary Disease and Diabetes. (2019) (198)
Randomized Comparison of Renal Denervation Versus Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension: Six-Month Results From the Prague-15 Study (2015) (189)
Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction (2008) (182)
Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study (2016) (169)
Long-Term Prognosis of Patients With Takotsubo Syndrome. (2018) (164)
Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. (2010) (163)
Blood pressure changes after renal denervation at 10 European expert centers (2013) (159)
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary ste (2015) (158)
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. (2005) (157)
Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. (2002) (153)
Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. (2008) (153)
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. (2009) (149)
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial (2009) (145)
Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8 (2008) (143)
Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry (2011) (141)
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. (2009) (140)
Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial. (2013) (133)
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial. (2017) (133)
Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study ‘Prague 19’ (2014) (132)
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. (2015) (128)
2010 Focused Update of ESC Guidelines on device therapy in heart failure (2010) (128)
Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy? (2011) (128)
The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale. (2009) (125)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017) (124)
Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study (2012) (119)
1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor. (2018) (119)
Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 Trial. (2007) (106)
How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? (2010) (102)
How to set up an effective national primary angioplasty network: lessons learned from five European countries. (2009) (98)
Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51). (2013) (95)
"Stent 4 Life" targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac Care. (2009) (94)
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. (2007) (91)
Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO study☆ (2002) (90)
Routine immediate extubation for off-pump coronary artery bypass grafting without thoracic epidural analgesia. (2002) (86)
Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program. (2013) (84)
Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: experience from the PRAGUE studies. (2006) (84)
Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial. (2019) (83)
Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study. (2007) (83)
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study (2001) (82)
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. (2009) (79)
Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass grafting. (2007) (79)
Pantoprazole to Prevents Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-blind, Placebo-controlled Trial. (2019) (79)
Procedural volume and outcomes with radial or femoral access for coronary angiography and intervention. (2014) (78)
Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study (2016) (75)
Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. (2010) (75)
The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry. (2007) (72)
Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study. (2014) (71)
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial. (2013) (70)
Systematic adjudication of myocardial infarction end-points in an international clinical trial (2001) (70)
Long-term survival following acute heart failure: the Acute Heart Failure Database Main registry (AHEAD Main). (2013) (69)
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial. (2009) (69)
Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension (2015) (67)
Early Tissue Distribution of Bone Marrow Mononuclear Cells After Transcoronary Transplantation in a Patient With Acute Myocardial Infarction (2005) (66)
Acute stroke therapy: A review. (2017) (66)
Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study. (2019) (65)
Eligibility for Renal Denervation: Experience at 11 European Expert Centers (2014) (63)
Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry (2019) (61)
A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction (2010) (59)
One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction (2007) (57)
Uric acid, allopurinol therapy, and mortality in patients with acute heart failure--results of the Acute HEart FAilure Database registry. (2012) (56)
Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). (2003) (55)
Shock index: a simple clinical parameter for quick mortality risk assessment in acute myocardial infarction. (2011) (54)
Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome. (2019) (54)
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation (2006) (53)
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry (2019) (53)
Implementation of primary angioplasty in Europe: stent for life initiative progress report. (2012) (52)
AHEAD score--Long-term risk classification in acute heart failure. (2016) (52)
Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long‐term anticoagulation (PRAGUE‐17 study) (2017) (52)
Left Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17. (2021) (51)
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries. (2016) (51)
Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial. (2015) (51)
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries. (2016) (50)
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease (2020) (49)
One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry. (2012) (46)
Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study (2011) (46)
Thoracic epidural anesthesia for off-pump coronary artery bypass without intubation. (2001) (45)
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes. (2011) (45)
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). (2010) (45)
Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial (2014) (44)
Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET). (2008) (44)
Next day discharge after successful primary angioplasty for acute ST elevation myocardial infarction. An open randomized study "Prague-5". (2008) (42)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke. (2019) (41)
High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration. (2011) (41)
One-year Outcomes of Prasugrel Versus Ticagrelor In Acute Myocardial Infarction Treated With Primary Angioplasty: The PRAGUE-18 Study (2017) (40)
Images in cardiovascular medicine. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. (2005) (40)
The impact of gender on outcomes of patients with ST elevation myocardial infarction transported for percutaneous coronary intervention: analysis of the PRAGUE-1 and 2 studies (2007) (40)
Coexistence and outcome of coronary artery disease in Takotsubo syndrome. (2020) (40)
Pericardial involvement during the course of myocardial infarction. A long-term clinical and echocardiographic study. (1995) (40)
Platelet glycoprotein GP VI 13254C allele is an independent risk factor of premature myocardial infarction. (2010) (38)
Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences (2013) (37)
Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients (2013) (37)
Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS. (2004) (37)
Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans. (1993) (37)
[OP.7D.09] THE ROLE OF ADDING SPIRONOLACTONE AND RENAL DENERVATION IN TRUE RESISTANT HYPERTENSION. ONE-YEAR OUTCOMES OF RANDOMIZED PRAGUE-15 STUDY (2016) (36)
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. (2009) (36)
The incidence and outcomes of acute coronary syndromes in a central European country: results of the CZECH-2 registry. (2014) (34)
The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: Insights from the COMPASS Trial. (2020) (32)
Evaluation of collateral blood flow by myocardial contrast enhanced echocardiography. (1988) (31)
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation (2013) (31)
Age-Related Variations in Takotsubo Syndrome. (2020) (31)
Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial (2020) (30)
Both Selective and Non-Selective His Bundle, but not Myocardial, Pacing Preserve Ventricular Electrical Synchrony Assessed by Ultra-High-Frequency ECG. (2019) (30)
Randomized comparison of endothelial progenitor cells capture stent versus cobalt‐chromium stent for treatment of ST‐elevation myocardial infarction. Six‐month clinical, angiographic, and IVUS follow‐up (2010) (30)
Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study (2017) (29)
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI) (2020) (29)
Factors Influencing Clopidogrel Efficacy in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention: Statin's Advantage and the Smoking “Paradox” (2009) (29)
Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically? (2014) (28)
Mortality Implications of Primary Percutaneous Coronary Intervention Treatment Delays: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial (2011) (28)
A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study. (2011) (28)
Spectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathy (2012) (28)
Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program (2013) (28)
Echocardiography in sarcoidosis. (1984) (27)
Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: Insights From the International Takotsubo Registry. (2019) (27)
Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy. (2016) (27)
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes (2017) (27)
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial (2020) (26)
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX (2015) (25)
High leukocyte count and interleukin-10 predict high on-treatment-platelet-reactivity in patients treated with clopidogrel (2012) (25)
First month course of left ventricular asynergy after intracoronary thrombolysis in acute myocardial infarction. A longitudinal echocardiographic study. (1985) (25)
Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization. (2007) (25)
Incidence and Outcomes Associated With Early Heart Failure Pharmacotherapy in Patients With Ongoing Cardiogenic Shock (2014) (24)
ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation (2013) (24)
Bleeding and New Cancer Diagnosis in Patients with Atherosclerosis. (2019) (24)
Stent for Life: how this initiative began? (2012) (23)
Renal disease and acute coronary syndrome (2009) (23)
Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: a genetic substudy of the PRAGUE-8 trial. (2010) (23)
Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy. (2013) (23)
Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis. (2013) (22)
SHOCK INDEX: A SIMPLE CLINICAL PARAMETER FOR QUICK MORTALITY RISK ASSESSMENT IN ACUTE MYOCARDIAL INFARCTION (2008) (22)
The role of cardiologists in stroke prevention and treatment: position paper of the European Society of Cardiology Council on Stroke (2018) (22)
Prevalence of stress-induced myocardial stunning (Tako-Tsubo cardiomyopathy) among patients undergoing emergency coronary angiography for suspected acute myocardial infarction. (2007) (21)
Impact of aspirin on takotsubo syndrome: a propensity score‐based analysis of the InterTAK Registry (2019) (21)
Prevalence and clinical significance of liver function abnormalities in patients with acute heart failure. (2014) (21)
Stent thrombosis--risk assessment and prevention. (2010) (21)
Transfer Times and Outcomes in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Interhospital Transfer for Primary Percutaneous Coronary Intervention: APEX-AMI Insights (2012) (20)
Positive Influence of Being Overweight/Obese on Long Term Survival in Patients Hospitalised Due to Acute Heart Failure (2015) (20)
Diurnal Variation of Soluble E- and P-Selectin, and Intercellular Adhesion Molecule-1 in Patients with and without Coronary Artery Disease (2004) (20)
Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial). (2014) (20)
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2017) (20)
ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison. (2016) (20)
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. (2013) (20)
Clinical Predictors and Prognostic Impact of Recovery of Wall Motion Abnormalities in Takotsubo Syndrome: Results From the International Takotsubo Registry (2019) (19)
Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update. (2016) (19)
Electrocardiographic changes can precede the development of myocardial hypertrophy in the setting of hypertrophic cardiomyopathy. (1989) (19)
Feasibility and safety of direct catheter-based thrombectomy in the treatment of acute ischaemic stroke. Cooperation among cardiologists, neurologists and radiologists. Prospective registry PRAGUE-16. (2017) (19)
Pharmacodynamic Effect of Clopidogrel in Patients Undergoing Transcatheter Aortic Valve Implantation (2013) (18)
Performance of the resolute zotarolimus‐eluting stent in small vessels (2014) (18)
Profile of patients with acute heart failure and elevated troponin I levels. (2007) (18)
Primary angioplasty vs. thrombolysis: the end of the controversy? (2009) (18)
Intracoronary transplantation of bone marrow stem cells: background, techniques, and limitations (2006) (18)
Rivaroxaban in Patients Stabilized after a ST-Elevation Myocardial Infarction: Results from the ATLAS ACS 2-TIMI 51 Trial. (2013) (18)
High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial (2009) (18)
Catheter-based interventions for acute ischaemic stroke (2015) (17)
Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventions (2015) (17)
Off-pump versus on-pump coronary artery bypass grafting surgery in high-risk patients: PRAGUE-6 trial at 30 days and 1 year. (2016) (17)
Complications after intracoronary stem cell transplantation in idiopathic dilated cardiomyopathy. (2006) (17)
Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table (2019) (16)
ECG in patients with acute heart failure can predict in-hospital and long-term mortality (2014) (16)
ORIGINAL RESEARCH—PHARMACOTHERAPY: Hemodynamic Effects of Sildenafil Citrate and Isosorbide Mononitrate in Men with Coronary Artery Disease and Erectile Dysfunction (2005) (16)
Direct Catheter-Based Thrombectomy for Acute Ischemic Stroke: Outcomes of Consecutive Patients Treated in Interventional Cardiology Centers in Close Cooperation With Neurologists. (2015) (16)
Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial Infarction. (2019) (15)
Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel (2015) (15)
Five-year outcomes in cardiac surgery patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation. The long-term follow-up of the PRAGUE-12 Study. (2019) (15)
Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study. (2015) (15)
Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness. (2010) (15)
Expert consensus statement of the Czech Society of Cardiology and the Czech Society of Hypertension on catheter-based sympathetic renal denervation procedures (RDN) in the Czech Republic (2012) (14)
Prediction of short‐ and long‐term mortality in takotsubo syndrome: the InterTAK Prognostic Score (2019) (14)
MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty (2021) (14)
Echocardiographic picture in diabetes mellitus. (1984) (13)
An international survey of clinical practice during primary percutaneous coronary intervention for ST-elevation myocardial infarction with a focus on aspiration thrombectomy. (2013) (13)
Acute heart failure registry from high-volume university hospital ED: comparing European and US data. (2012) (13)
Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy. (2009) (13)
Stent or balloon: How to treat proximal internal carotid artery occlusion in the acute phase of ischemic stroke? Results of a short survey (2016) (13)
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations. (2015) (13)
Catheter-based renal denervation versus intensified medical treatment in patients with resistant hypertension: Rationale and design of a multicenter randomized study—PRAGUE-15 (2014) (13)
Reimplantation of anomalous right coronary artery arising from the pulmonary trunk leading to normal coronary flow reserve late after surgery. (2003) (13)
Three-year outcomes of percutaneous coronary intervention with next-generation zotarolimus-eluting stents for de novo coronary bifurcation lesions. (2014) (13)
Severe diffuse hypokinesis of the remote myocardium--the main cause of cardiogenic shock? An echocardiographic study of 75 patients with extremely large myocardial infarctions. (1988) (13)
Impact of body mass index on long‐term clinical outcomes after second‐generation drug eluting stent implantation: Insights from the international global RESOLUTE program (2015) (12)
Abstract 3007: Glycoprotein IIb/IIIa Inhibitors before Primary Percutaneous Coronary Intervention of ST-Elevation Myocardial Infarction Improve Perfusion and Outcomes: Insights from APEX-AMI (2007) (12)
Prevalence of coronary atherosclerosis in asymptomatic population. (2000) (12)
Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program. (2013) (12)
One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: The PRAGUE-19 Study (2015) (12)
Comparison of outcomes in ST-segment depression and ST-segment elevation myocardial infarction patients treated with emergency PCI: data from a multicentre registry (2012) (12)
Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (2017) (11)
Gender differences in total cholesterol levels in patients with acute heart failure and its importance for short and long time prognosis. (2012) (11)
Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascular Interventions with the support of the European Board of Neuroin (2021) (11)
Risk of in-hospital mortality identified according to the typology of patients with acute heart failure: classification tree analysis on data from the Acute Heart Failure Database-Main registry. (2013) (11)
Why we are not able to find the coronary heart disease gene - apoE as an example. (2010) (11)
The year in cardiology 2018: acute coronary syndromes. (2019) (11)
Transcatheter aortic valve implantation: long-term clinical outcome and valve durability (2015) (11)
A randomized, double‐blind, placebo‐controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics (2019) (11)
Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry (2021) (11)
Effect of papaverine administration on myocardial echocontrast distribution. (1987) (10)
Prevalence and predictors of coronary artery disease in patients undergoing carotid artery stenting (2019) (10)
Influence of primary coronary intervention on myocardial collagen metabolism and left ventricle remodeling predicted by collagen metabolism markers. (2005) (10)
Serum Dickkopf-1 signaling and calcium deposition in aortic valve are significantly related to the presence of concomitant coronary atherosclerosis in patients with symptomatic calcified aortic stenosis (2015) (10)
ST elevation myocardial infarction treated with bioresorbable vascular scaffold: rationale and first cases. (2013) (10)
The influence of age on clinical outcomes in patients treated with the resolute zotarolimus‐eluting stent (2016) (10)
Renal function assessed using cystatin C and antiplatelet efficacy of clopidogrel assessed using the vasodilator-stimulated phosphoprotein index in patients having percutaneous coronary intervention. (2012) (10)
Real-World Safety and Effectiveness Outcomes of a Zotarolimus-Eluting Stent: Final 3-Year Report of the RESOLUTE International Study (2013) (10)
Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study (2016) (10)
Potential role of invariant natural killer T cells in outcomes of acute myocardial infarction. (2015) (9)
Enteric-coated aspirin in cardiac patients: Is it less effective than plain aspirin? (2018) (9)
Perioperative cardiovascular complications versus perioperative bleeding in consecutive patients with known cardiac disease undergoing non-cardiac surgery. Focus on antithrombotic medication. The PRAGUE-14 registry (2014) (9)
An analysis of TRITON-TIMI 38, based on the 12 month recommended length of therapy in the European label for prasugrel (2014) (9)
Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program. (2016) (9)
Technical and safety aspects of renal denervation (2014) (8)
Acute myocardial infarction complicated by shock: outcome analysis based on initial electrocardiogram (2014) (8)
Direct catheter-based thrombectomy in acute ischaemic stroke performed collaboratively by cardiologists, neurologists and radiologists: the single-centre pilot experience (PRAGUE-16 study). (2014) (8)
Variable penetration of primary angioplasty in Europe--what determines the implementation rate? (2012) (8)
The use of revascularization strategies in patients with acute coronary syndromes admitted to hospitals without catheterization facilities: Results from the ALERT-CZ registry (2013) (8)
Clopidogrel up-titration versus standard dose in patients with high residual platelet reactivity after percutaneous coronary intervention: a single-center pilot randomised study. (2011) (8)
THE RELATIONSHIP BETWEEN SHORT AND LONG–TERM ANTIPLATELET THERAPY USE AND STENT THROMBOSIS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH THE RESOLUTE ZOTAROLIMUS–ELUTING STENT (2013) (8)
Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease (2013) (8)
Summary of the 2012 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevations. Prepared by the Czech Society of Cardiology☆ (2012) (8)
An embolus in the right atrium caught in the Chiari network and resistant to thrombolysis (2010) (8)
Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study (2020) (8)
Clinical experience with Albunex: a standard echocontrast agent for intravenous and intracoronary use. (1991) (8)
The impact of age and Killip class on outcomes of primary percutaneous coronary intervention. Insight from the PRAGUE-1 and -2 trials and registry. (2007) (7)
Does previous hypertension affect outcome in acute heart failure? (2011) (7)
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program. (2016) (7)
Ischaemic stroke and ST-segment elevation myocardial infarction: fast-track single-stop approach. (2015) (7)
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel (2009) (7)
Recent atrial fibrillation in acute myocardial infarction: a sign of pericarditis. (1993) (7)
Incidence, treatment strategies and outcomes of acute coronary syndrome with and without ongoing myocardial ischaemia: results from the CZECH-3 registry (2019) (7)
Predictors of complete arrhythmia free survival in patients undergoing surgical ablation for atrial fibrillation. PRAGUE-12 randomized study sub-analysis. (2014) (7)
Stable Clinical Outcomes When a Stroke Thrombectomy Program Is Started in an Experienced Cardiology Cath Lab. (2021) (7)
Acute myocardial infarction complicated by early onset of heart failure: safety and feasibility of interhospital transfer for coronary angioplasty. Subanalysis of Killip II-IV patients from the PRAGUE-1 study. (2003) (7)
Degenerative changes and immune response after transcatheter aortic valve implantation. Comparison with surgical aortic valve replacement. (2017) (7)
Original research article - Special issue: Acute Ischemic Stroke The importance of time: Time delays in acute stroke (2016) (7)
The potential value of histological analysis of thrombi extracted through mechanical thrombectomy during acute ischemic stroke treatment (2020) (6)
Is bivalirudin just an expensive heparin? (2016) (6)
Pericardial Effusion as a Consequence of Acute Myocardial Infarction (1999) (6)
Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry (2021) (6)
Intracoronary Albunex: Its Effects on Left Ventricular Hemodynamics, Function, and Coronary Sinus Flow in Humans (1993) (6)
Clopidogrel resistance "Live" – the risk of stent thrombosis should be evaluated before procedures (2009) (6)
Absorb bioresorbable stents for the treatment of coronary artery disease (2015) (6)
Hyperuricemia treatment in acute heart failure patients does not improve their long‐term prognosis: A propensity score matched analysis from the AHEAD registry (2019) (6)
LUCAS II Device for Cardiopulmonary Resuscitation in a Nonselective Out-of-Hospital Cardiac Arrest Population Leads to Worse 30-Day Survival Rate Than Manual Chest Compressions. (2020) (6)
Perspectives on training requirements for interventional cardiologists to perform endovascular interventions for acute ischaemic stroke. (2019) (6)
Very long-term outcome of ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study. (2019) (6)
Hemodynamic effects of sildenafil citrate and isosorbide mononitrate in men with coronary artery disease and erectile dysfunction. (2005) (6)
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1. (2019) (6)
Periprocedural antithrombotic medication in acute ischemic stroke treated by catheter-based thrombectomy. A review (2015) (5)
Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions. (2016) (5)
Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment. (2020) (5)
Autoantibodies in hypertrophic cardiomyopathy and their clinical significance. (1987) (5)
Worse prognosis of real‐world patients with acute heart failure from the Czech AHEAD registry in comparison to patients from the RELAX‐AHF trial (2016) (5)
Stent for Life Initiative: where are we standing and where are we going? (2012) (5)
Acute coronary syndromes with ongoing myocardial ischemia (ACS with OMI) versus acute coronary syndromes without ongoing ischemia (ACS without OMI) (2013) (5)
[Guidelines in cardiac pacing and resynchronization therapy]. (2007) (5)
Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry. (2007) (5)
Corrigendum to: Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries (2014) (5)
Clinical correlates and prognostic impact of neurologic disorders in Takotsubo syndrome (2021) (5)
THE RESOLUTE ZOTAROLIMUS-ELUTING STENT IN PATIENTS WIH DIABETES MELLITUS: TWO YEAR OUTCOMES (2012) (5)
Risk of a coronary event in patients after ischemic stroke or transient ischemic attack. (2021) (4)
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions. (2015) (4)
Evolving strategies in the management of acute coronary syndromes with oral antiplatelet agents (2012) (4)
Trends in epidemiology and the treatment of acute coronary syndromes in the Czech Republic: Comparison of the CZECH-1 and CZECH-2 registries (2014) (4)
Patterns of Long‐term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI‐38 Coronary Stent Registry (2014) (4)
Czech Republic and low COVID-19 mortality in the heart of Europe: possible explanations (2020) (4)
Pacemaker reprogramming rarely needed after device replacement (2019) (4)
Renal denervation: the hope for patients with refractory hypertension? (2011) (4)
ESC Guidelines on the management of acute myocardial infarction with persistent ST-segment elevation (2012) (4)
[Practice guidelines 2007 for the treatment of arterial hypertension]. (2007) (4)
Two-dimensional echocardiography in acute transmural and non-transmural myocardial infarction. (1984) (4)
Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study. (2016) (4)
The comparison of platelet activity between patients with patent vs. occluded coronary artery bypass grafts. (2007) (4)
Summary of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Prepared by the Czech Society of Cardiology ☆ (2016) (4)
Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial. (2021) (4)
Modified Strategies for Invasive Management of Acute Coronary Syndrome during the COVID-19 Pandemic (2020) (4)
Protocols of antithrombotic therapy in a University Cardiocenter (2013) (3)
Distribution of hypertrophy in obstructive and non-obstructive types of hypertrophic cardiomyopathy. (1984) (3)
Possibilities and limitations of myocardial flow reserve (1994) (3)
Increasing the Penetration of Primary Angioplasty in Europe (2011) (3)
Endovascular thrombectomy 2020: open issues (2020) (3)
Cardioprotective effects of adenosine transport inhibition during reversible ischaemia in patients with coronary artery disease. (1999) (3)
Design and Rationale of the PRAGUE‐12 Trial: A Large, Prospective, Randomized, Multicenter Trial That Compares Cardiac Surgery With Left Atrial Surgical Ablation With Cardiac Surgery Without Ablation in Patients With Coronary and/or Valvular Heart Disease Plus Atrial Fibrillation (2012) (3)
Clinical outcomes of acute ischemic stroke patients treated by direct catheter-based trombectomy depending on their baseline characteristics (2018) (3)
"PRAGUE" randomized clinical trials: pride of Czech cardiology (2009) (3)
Stent thrombosis in acute coronary syndromes: Patient-related factors and operator-related factors (2020) (3)
Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial (2016) (3)
Risk comparison of bleeding and ischemic perioperative complications after acute and elective orthopedic surgery in patients with cardiovascular disease (2016) (3)
Clopidogrel Before Elective Percutaneous Coronary Intervention (2010) (3)
Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry (2021) (3)
Acute myocardial infarction and acute stroke: What are the differences? Focus on reperfusion therapy (2013) (3)
Acute myocardial infarction due to the left main coronary artery occlusion: Electrocardiographic patterns, angiographic findings, revascularization and in-hospital outcomes (2012) (3)
Variants in miRNA Regulating Cardiac Growth Are Not a Common Cause of Hypertrophic Cardiomyopathy (2015) (3)
Near‐normal coronary angiography in a patient, who is entirely asymptomatic 24 years after successful intracoronary thrombolysis for ST elevation myocardial infarction. Follow‐up of the historically first Czech intracoronary thrombolysis patient (2007) (3)
I have an acute myocardial infarction: open my coronary artery, stent it and keep full flow! (2002) (3)
Long-term outcomes of thrombectomy for acute ischaemic stroke by occluded artery and stroke aetiology: a PRAGUE-16 substudy (2021) (3)
The effect of left atrial appendage closure on heart failure biomarkers: A PRAGUE‐17 trial subanalysis (2021) (3)
Diffuse left ventricular hypokinesis in cardiogenic shock--its cause or consequence? (1984) (3)
Platelet-derived chemokines, PF-4 and RANTES, are significantly increased in hemodynamically significant degenerative aortic stenosis. (2011) (2)
Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events (2022) (2)
Inter-hospital transport for primary angioplasty does not compromise left ventricular function: six-month echocardiographic follow-up of the PRAGUE 1 Study. (2003) (2)
The influence of occluded artery and etiology of acute ischemic stroke on the long term outcomes after thrombectomy. A PRAGUE-16 substudy. (2020) (2)
Haematological manifestation of coeliac disease in a young patient with myocardial infarction (2009) (2)
The role of echocardiography in a coronary care unit. (1985) (2)
Electrocardiogram changes due to myocardial infarction in a patient with selective His bundle pacing. (2019) (2)
Potential applications for transesophageal echocardiography in hypertrophic cardiomyopathies. (1992) (2)
Heart rate as an independent predictor of long term mortality of acute heart failure patients in sinus rhythm according to their ejection fraction: data from the AHEAD registry. (2020) (2)
Rationale , Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s ( COMPASS ) Trial (2017) (2)
The time has come for new, more precise guidelines in the treatment of high-risk acute coronary syndromes with heparin. (2008) (2)
Right subclavian approach in transcatheter aortic valve implantation using the CoreValve prosthesis (2012) (2)
Fakta a úvahy o pandemii COVID-19 (2020) (2)
Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation. (2012) (2)
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. (2022) (2)
Prospective use of EuroSCORE for the short-term risk evaluation of consecutive cardiac surgery candidates: are there any differences in prediction of perioperative risk versus risk of nonsurgical treatments? (2006) (2)
Severe Left Ventricular Systolic Dysfunction is Independently Associated with High On-Clopidogrel Platelet Reactivity (2014) (2)
Acute ischaemic stroke in atrial fibrillation: worse outcomes unrelated to treatment methods. (2017) (2)
3300MiR-126-3P and MiR-223-3p in Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty, The Prague-18 Genetic Sub-study (2019) (2)
Reperfusion damage or no-reflow damage in primary coronary interventions in acute myocardial infarction? (2002) (2)
Acute Revascularization in ST-Segment-Elevation Myocardial Infarction (2014) (2)
Mechanical circulatory support: harm without benefit? Fascinated by devices, cardiologists may lose common sense. (2017) (2)
Traumatic acute myocardial infarction due to the blunt mid-chest trauma during ice-hockey game (2012) (2)
Abstract 18805: Vorapaxar, A Platelet Thrombin-Receptor Antagonist, in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from the TRACER Trial (2012) (2)
Impact of antecedent hypertension on outcomes in patients hospitalized with severe forms of acute heart failure (2012) (2)
[Normal values of echocardiographic parameters]. (1981) (2)
Left atrial appendage closure - ready for widespread clinical use? (2020) (2)
Electrocardiography in different types of hypertrophic cardiomyopathies. (1985) (2)
Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease (2021) (2)
RESISTANCE TO CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IS A NEGATIVE PROGNOSTIC FACTOR IN PATIENTS UNDERGOING ELECTIVE PCI FOR STABLE CORONARY ARTERY DISEASE: ANALYSIS FROM LABORATORY SUBSTUDY OF PRAGUE 8 TRIAL (2010) (2)
Pharmacological versus catheter-based reperfusion: What is present state of the art? (2001) (2)
Trends in the treatment and outcomes of elderly patients with acute coronary syndrome: Results from the CZECH registries (2017) (1)
Abstract 10994: Use of Aspiration Thrombectomy and Practice Patterns During Primary PCI for STEMI – Results of an International Survey (2010) (1)
Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial (2018) (1)
Subject Index Vol. 102, 2004 (2004) (1)
The possibility of non-invasive identification of occluded coronary artery in acute myocardial infarction. A comparison of ECG and echocardiography with coronary arteriography or autopsy. (1986) (1)
Arrhythmogenic left ventricular dysplasia (2010) (1)
The course of myocardial hypertrophy in hypertrophic cardiomyopathy. Results of a 10-year follow-up. (1993) (1)
[Immunogenetic study in hypertrophic cardiomyopathy]. (1992) (1)
Two-dimensional echocardiography in evaluating left ventricular function. (1984) (1)
Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study (2017) (1)
Thrombectomy for stroke by cardiologists. (2018) (1)
Abstract 13993: Impact of Prasugrel Pretreatment and Timing of Coronary Artery Bypass Grafting on Clinical Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction: From the Accoast Study (2014) (1)
CRT-70 The Resolute Zotarolimus-eluting Stent Is Equally Safe And Effective In Women And Men With Coronary Artery Disease: Two-year Outcomes From The Pooled Resolute Clinical Program (2013) (1)
THA and TKA in patients with cardiovascular disease: What makes the risk of perioperative bleeding? (2016) (1)
[Neuro-cardiology or cardio-neurology - a new specialization of the future?]. (2015) (1)
Use of verapamil in the treatment of hypertrophic cardiomyopathy. (1986) (1)
DURATION OF DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENT TREATMENT BY GEOGRAPHIC REGION (2012) (1)
Abstract 4018: The Comparison of Clopidogrel Effectiveness in Patients with Hemodynamically Stable vs. Unstable Acute Myocardial Infarction (2008) (1)
Comparison of Cationic Propyl Gallate and Adenosine Diphosphate for the Meassurement of Aspirin Effectivity with Optical Aggregometry. (2005) (1)
Thrombolysis vs. PTCA vs. both in patients with acutemyocardial infarction (Prague trial) : coronarography findingsand PTCA results. (1999) (1)
Collateral flow and restenosis : appreciating hydraulics and outcomes of percutaneous coronary intervention (2000) (1)
Echocardiography during attack of angina pectoris. (1983) (1)
Clinical and radiological factors predicting stroke outcome after successful mechanical intervention in anterior circulation (2022) (1)
TCT-639 Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ≤2.5 mm Diameter (2012) (1)
Coronary Interventions in the Czech Republic and Trends in theUse of Radial Approach (2012) (1)
Stroke in cardiovascular interventions. (2017) (1)
Stroke management by cardiologists. (2017) (1)
When will acute stroke interventions be as widely available as primary PCI? (2017) (1)
Antiplatelet therapy in patients after an acute coronary syndrome: Comparison of the Czech and Slovak Republics Results of the ATHRO registry (2014) (1)
The ‘PRAGUE’ Trials series, part 1 (2017) (1)
Resolute zotarolimus-eluting coronary stent system for the treatment of coronary artery disease (2014) (1)
[Reproducibility of echocardiographic measurements]. (1983) (1)
Ineffectiveness of verapamil in reducing myocardial hypertrophy in hypertrophic cardiomyopathy (1987) (1)
P756Renal denervation in comparison to intensified pharmacotherapy in true resistant hypertension. Two-year outcomes of randomised PRAGUE-15 study (2017) (1)
[The optimal diagnostic approach in myocardial infarct]. (1993) (1)
Possibilities of two-dimensional echocardiography in cardiomyopathies. (1984) (1)
Transportation to primary percutaneous coronary intervention, compared with on-site fibrinolysis, is a strong independent predictor of functional status after myocardial infarction: 5-year follow-up of the PRAGUE-2 trial (2014) (1)
[Initial experience with selective intracoronary thrombolytic therapy]. (1983) (1)
Myocardial contrast two-dimensional echocardiography: initial observations during cardiac catheterization (1988) (1)
Cardiac rhythm disorders in various types of hypertrophic cardiomyopathies. (1989) (1)
Intracoronary drug delivery: mechanically too rough, pharmacologically too weak? (2000) (1)
Relationship between symptom-onset-to-balloon time and outcomes in patients with acute myocardial infarction treated with primary percutaneous coronary intervention (2020) (1)
Acute ischaemic stroke: recent advances in reperfusion treatment (2022) (1)
The Appearance and Disappearance Time of Effusions * Table 4 . Relation Between the Size of Effusion and Clinical Signs of Pericarditis * (0)
Chapter 9 PCI for acute coronary syndromes (including STEMI) (2010) (0)
RISK STRATIFICATION AND EFFECTS OF PERCUTANEOUS CORONARY INTERVENTION AND THE PHARMACOTHERAPY INITIATED IN THE FIRST 24 HOURS ON IN-HOSPITAL MORTALITY IN PATIENTS WITH THE FIRST MYOCARDIAL INFARCTION: PP.29.421 (2011) (0)
Outcomes of patients hospitalized for suspected acute coronary syndrome, in whom the diagnosis was not confirmed: Results from the CZECH-1 and CZECH-2 registries (2015) (0)
Acute ischemic stroke with medial cerebral artery hyperdense sign — /INS;Comparison of intravenous thrombolysis and catheter-based therapy: A pilot study (2013) (0)
Chapter 1 History, principles, normal values, techniques (2010) (0)
Chapter 45 Percutaneous coronary interventions in patients with acute coronary syndromes (2010) (0)
Abstract 2326: Impact of Persistent Cardiac Dyssynchrony on Functional Outcomes in Patients with Viable Myocardium Undergoing Surgical Myocardial Revascularization (2006) (0)
The ‘PRAGUE’ Trials series, part 2 (2017) (0)
Catheterization and Interventional Cardiology in Adult Patients (2010) (0)
[Relation between disorders of cardiac rhythm to the symptomatology and extent of hypertrophic cardiomyopathy]. (1989) (0)
How to optimally prepare a patient for planned coronary angiography and subsequent angioplasty (2007) (0)
Intracoronary thrombolytic treatment in myocardial infarction and unstable angina pectoris. (1985) (0)
Direct transfer of acute stroke patients to angiography suites equipped with flat-detector computed tomography: literature review and initial single-centre experience (2022) (0)
Intramyocardial distribution of bone marrow stem cells implanted into coronary artery in patients with acute or chronic myocardial infarction and its relation to the change of left ventricular function during follow-up (2007) (0)
Barriers in the implementation of guidelines for acute coronary syndromes. Focus on antiplatelet therapy (2017) (0)
Ten years mortality in STEMI patients in the era of primary percutaneous coronary intervention (2013) (0)
The implementation of primary PCI services in Argentina: a real challenge (2019) (0)
In-hospital Death Prediction by Multilevel Logistic Regression in Patients with Acute Coronary Syndromes (2013) (0)
Abstract 16391: The Impact of Smoking on Clinical Outcomes and the Role of Double-Dose versus Standard-Dose Clopidogrel Among Individuals With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention - Insights From the CURRENT-OASIS 7 Trial (2016) (0)
[Transcutaneous aortovelography in the diagnosis of aortic stenosis in children and adolescents]. (1984) (0)
Clinical outcomes for prasugrel versus clopidogrel are consistent among patients from TRITON-TIMI 38 with unstable angina or non-ST-elevation myocardial infarction (2013) (0)
An immunogenetic study in hypertrophic cardiomyopathy. (1991) (0)
Liver and AHF (2013) (0)
The incidence of right bundle branch block in acute myocardial infarction (2010) (0)
[Drug-eluting stents--for all, for some or for none?--Editorial]. (2007) (0)
“Incidence of and Outcomes Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention” Jerome Chambers - “Genetic Alterations Associated with Cryptorchidism” Wanda Averhart - “Clinical trial: A Multistrain Probiotic Preparation Significa (2009) (0)
Treatment of ST elevation acute myocardial infarction in Europe (2010) (0)
How important is telemedicine in the early phase of STEMI (2015) (0)
[Is it possible to non-invasively detect an occluded coronary artery in acute myocardial infarct? Comparison of EKG and echocardiography with coronarography or autopsy]. (1987) (0)
Transcatheter aortic valve implantation (TAVI) using the CoreValve prosthesis - initial experience in Královské Vinohrady University Hospital, advantages and pitfalls of the new method (2010) (0)
[Mesothelioma of the pericardium diagnosed by echocardiography]. (1984) (0)
[Contribution to a discussion on the future relations between cardiology and internal medicine]. (1994) (0)
THE IMPORTANCE OF BLOOD PRESSURE FOR THE PROGNOSIS OF PATIENT HOSPITALISED WITH ACUTE HEART - ACUTE HEART DATABASE (AHEAD) REGISTRY: PP.40.295 (2011) (0)
[Incidence of ECG changes in the relatives of patients with hypertrophic cardiomyopathy without concurrent myocardial hypertrophy]. (1988) (0)
[Two-dimensional echocardiography for left ventricular function evaluation (author's transl)]. (1982) (0)
Cost effectiveness analysis of out-patient and remote monitoring of patients after pacemaker replacement from the perspective of the health care payer (2018) (0)
Thrombosis—the central problem in clinical cardiology (2013) (0)
[Echocardiographic detection of wedged emboli in the right heart in patients with pulmonary embolisms]. (1991) (0)
PLATELETS AND HAEMOSTATIC GENE POLYMORPHISMS AND RISK OF BLEEDING IN PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY: ANALYSIS OF THE PRAGUE-8 GENETIC SUBSTUDY (2009) (0)
[Personal experience with the long-term administration of verapamil in hypertrophic cardiomyopathies]. (1986) (0)
More evidence-based data are required for a consensus on the aetiology of the so-called Brugada Syndrome (2003) (0)
P1787Immune-inflammatory response after bioresorbable vascular scaffold implantation in patients with acute myocardial infarction with ST elevation in a long-term perspective (2017) (0)
Abstract 3009: Major Subgroup Analyses from the FINESSE Trial: Evaluation of Abciximab + Half -Dose Reteplase, Abciximab Alone, or Placebo for Facilitation of Primary PCI for ST Segment Elevation MI (2007) (0)
THE TIME HAS COME FOR NEW, MORE PRECISE GUIDELINES IN THE TREATMENT OF HIGH RISK ACUTE CORONARY SYNDROMES WITH HEPARIN (2007) (0)
Interdisciplinary cooperation for a maximum acceleration of availability of modern therapy for ischemic stroke for all patients in need of endovascular thrombectomy. (2019) (0)
The picture of hypertrophic cardiomyopathy in the elderly. (1988) (0)
Myocardial contrast echocardiography. A review of clinical studies. (1988) (0)
TCT-649 Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program (2012) (0)
(Facts and thoughts on COVID-19 pandemic) (2020) (0)
The many roles of urgent catheter interventions: from myocardial infarction to acute stroke and pulmonary embolism (2023) (0)
P5337Predictors and case fatality rate of perioperative major cardiovascular events in cardiac patients undergoing non-cardiac surgery (2017) (0)
Evaluation ofcollateral bloodflowbymyocardial contrastenhanced echocardiography (1988) (0)
Cardiovascular risk factors in patients with acute coronary syndromes treated in non-academic hospitals — Incidence and awareness (2013) (0)
Guidelines on the identification and treatment of pulmonary hypertension. (2009) (0)
Serum Dickkopf-1 signaling and calcium deposition in aortic valve are significantly related to the presence of concomitant coronary atherosclerosis in patients with symptomatic calcified aortic stenosis (2015) (0)
One year follow up results of the FINESSE trial of facilitated PCI (2008) (0)
[Contralateral asynergy after myocardial infarct]. (1991) (0)
Acute coronary syndromes Contemporary registries on P 2 Y 12 inhibitors in patients with acute coronary syndromes in Europe : overview and methodological considerations (2015) (0)
The mortality benefit seen with the newer more potent oral P2Y12 inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis (2018) (0)
P4847 | BEDSIDE Clinical outcomes for prasugrel versus clopidogrel are consistent among patients from TRITON-TIMI 38 with unstable angina or non-ST-elevation myocardial infarction (0)
Review article - Special issue: Acute Ischemic Stroke The key messages from 2015 North American (US and Canada) Guidelines for the Early Management of Patients With Acute Ischemic Stroke: Focus on endovascular treatment (2016) (0)
[Hypertrophy of the left ventricle and septum in obstructive and non-obstructive types of hypertrophic cardiomyopathy]. (1983) (0)
Cellular therapy of coronary heart disease: a summary of state of the art, limitations and prospects. Part One. Introduction, techniques of myocardial cell transplantation, skeletal myoblasts. (2006) (0)
Coronary artery disease: coronaryrevascularization (2005) (0)
Indications for coronary artery bypass grafting (2006) (0)
New onset atrial fibrillation following myocardial infarction is a strong independent predictor of mortality in patients treated with primary percutaneous coronary intervention (2008) (0)
[Non-invasive diagnosis of aneurysms of the left ventricle by two-dimensional echocardiography (author's transl)]. (1981) (0)
In hospital mortality in paeitns hospitalized for acute heartfailure - AHEAD Main Registry (2010) (0)
TCT-404 ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-year results from a propensity score matched comparison. (2016) (0)
History of cardiovascular research at the Charles University (2020) (0)
The prognostic significance of periprocedural infarction in the era of potent antithrombotic therapy. The PRAGUE-18 substudy. (2020) (0)
[Modern treatment of acute ischemic stroke]. (2014) (0)
EVALUATION OF THE EFFICACY AND SAFETY OF OTAMIXABAN VS. UNFRACTIONATED HEPARIN+EPTIFIBATIDE IN ELDERLY PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES IN THE SEPIA-ACS1 TIMI 42 TRIAL (2011) (0)
Responsible for the PRAGUE Studies, Which Changed Clinical Practice, and Looking to Expand Its Research (2008) (0)
[Apical hypertrophic cardiomyopathy]. (1983) (0)
Antithrombotic therapy in patients at risk for coronary stent thrombosis undergoing non-cardiac surgery (2010) (0)
Patient characteristics, treatment strategy, outcomes, and hospital costs of acute coronary syndrome: 3 years of data from a large high-volume centre in Central Europe (2022) (0)
Abstract 5617: Paradoxical Low Use of Coronary Interventions in High-Risk Non-st Segment Acute Coronary Syndromes with Heart Failure. Data from the Oasis-5 Randomized Trial (2008) (0)
Emerging primary percutaneous coronary intervention as the dominant reperfusion strategy for myocardial infarction in Europe (2005) (0)
[The role of echocardiography in the coronary unit]. (1984) (0)
[Echocardiographic picture of the diabetic heart]. (1981) (0)
P2698Is stent thrombosis caused by patient-related factors or by operator-related factors? (2019) (0)
[Echocardiography in attacks of angina pectoris (author's transl)]. (1982) (0)
Otto Klein from Prague University Hospital performed the world first diagnostic cardiac catheterization in 11 Czech patients in 1929. (2020) (0)
Cellular therapy of coronary heart disease: a review of concepts, limitations, prospects. Part Two. Stem cells, prospects of cullular therapy (2006) (0)
[Failure of the left ventricle as a pump in hypertrophic cardiomyopathy]. (1987) (0)
Coronary artery ectasia (2008) (0)
[Is it possible to diagnose and better characterize hypertrophic cardiomyopathies using ECG?]. (1985) (0)
We-P13:316 Glycemia and triglycerides, but not total or HDL cholesterol levels, are associated with higher platelet activity (2006) (0)
[2-dimensional echocardiography in acute myocardial infarct]. (1982) (0)
[2-dimensional echocardiography in cardiomyopathies]. (1982) (0)
The Bioresorbable Stent in Perspective-How Much of an Advance is It? (2014) (0)
Myocardial contrast echocardiography: a new method for the evaluation of regional myocardial blood flow. (1988) (0)
[Unstable angina pectoris--pathogenesis and therapy]. (1989) (0)
Reply: Not All NSTEMIs Are Created Equal. (2015) (0)
[The Rotterdamm Thoraxcenter--the epitome of modern cardiology. I]. (1987) (0)
Clinical Features and Outcomes of Patients With Malignancy (2020) (0)
TRial to assess Improvement in Therapeutic outcomes by Optimizing platelet inhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) and Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysi (2014) (0)
Jiri Widimsky MD. (2021) (0)
Total Events and Net Clinical Benefit of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial (2023) (0)
[Echocardiographic diagnosis and monitoring of intracardiac thrombi]. (1985) (0)
[Huge sinus of Valsalva aneurysm in patient with cystic medial necrosis of the aorta]. (2004) (0)
NEUTROPHIL EXTRACELLULAR TRAPS (NETS) AND THROMBOLYSIS RESISTANCE - COMPARATIVE ANALYSIS OF THROMBOTIC/EMBOLIC SPECIMENS, RETRIEVED FROM CEREBRAL ARTERIES AFTER MECHANICAL THROMBECTOMY AND CORONARY ARTERY THROMBUS ASPIRATION IN MYOCARDIAL INFARCTION (2022) (0)
Clinical Study Pharmacodynamic Effect of Clopidogrel in Patients Undergoing Transcatheter Aortic Valve Implantation (2015) (0)
A piece of hammer in the right ventricle of the heart (2009) (0)
The Effect of Symptom Onset-to-needle time on Ischemic Outcomes in Patients Treated with Primary Angioplasty in the Era of Potent Antiplatelets (2021) (0)
A contemporary approach to a young female patient with Loeys-Dietz syndrome and an uncomplicated type B aortic dissection: a case report (2020) (0)
Trends in outcomes of women with myocardial infarction undergoing primary angioplasty—Analysis of randomized trials (2023) (0)
P504Comparison of outcomes of acute stroke patients with isolated middle cerebral artery occlusion versus terminal internal carotid artery (T-type) occlusion treated with endovascular intervention (2017) (0)
Abstract 396: Serum Osteoprotegerin (OPG) Differs Significantly in Patients with Calcified Aortic Valve Stenosis in Relation to the Presence of Coronary Atherosclerosis (2012) (0)
Intense antithrombotic therapy is necessary for long-term treatment in patients with symptomatic peripheral artery disease after acute myocardial infarction and primary PCI (2020) (0)
Edinburgh Research Explorer Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (2017) (0)
[Spectrum of echocardiographic findings in 400 individuals with mitral valve prolapse]. (1983) (0)
Left ventricular remodelling adaptation or maladaptation (2006) (0)
397. Perioperative disorders of hemostasis in cardiac patients in oncosurgery (2014) (0)
Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study (2020) (0)
Přehledový článek | Review article Nastal čas nahradit monoterapii kyselinou acetylsalicylovou v sekundární prevenci účinnější léčbou? (2022) (0)
Chapter 6 Left ventricular angiography and other angiocardiographic techniques (2010) (0)
[The echocardiographic picture in sarcoidosis]. (1984) (0)
Abstract 3631: Elevated In-hospital Glucose Level, and not Known History of Diabetes Mellitus, Predicts 30-day Mortality Following Acute ST-elevation Myocardial Infarction (2007) (0)
FREQUENCY, CLINICAL AND ANGIOGRAPHIC CHARACTERISTICS, AND OUTCOMES OF HIGH-RISK NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES PATIENTS WITH LEFT CIRCUMFLEX CULPRIT LESIONS (2012) (0)
Clinical findings in hypertrophic cardiomyopathy and their relationship to the disease severity. (1988) (0)
Percutaneous coronary intervention in a cheerful, one-hundred-year-old patient with acute coronary syndrome (2010) (0)
[What will internal medicine look like in developed countries in the 21st century?]. (1999) (0)
Abstract 19375: Platelet Activation Plays an Important Role in Regulation of Aortic Valve Calcification in Calcific Aortic Valve Disease (2016) (0)
The cardioprotective effects of trimetazidine (2016) (0)
Do women with acute heart failure differ from men (2010) (0)
[Myocardial infarct. Results and tactics in reperfusion therapy]. (1989) (0)
Interventional treatment of elderly patients with acute coronary syndrome (2008) (0)
Percutaneous coronary interventions in acute coronary syndromes (2018) (0)
[Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil]. (1987) (0)
Abstract 2935: Persistence of Severe Cardiac Dyssynchrony is Associated with Significant Morbidity and Mortality after CABG: a Study of 183 Patients with Ischemic Cardiomyopathy Undergoing CABG (2006) (0)
Abstract 2146: Drug Eluting Stents (DES) in AMI patients. Insights from FINESSE (2007) (0)
[Disorders of heart rhythm in hypertrophic cardiomyopathy]. (1989) (0)
Left atrial appendage occluders-new hope for stroke prevention in high-risk patients. (2022) (0)
[Contrast echocardiography of the heart muscle: a new method for the evaluation of regional perfusion]. (1988) (0)
CardioPulse: the Czech Society of Cardiology. (2013) (0)
Current cardiovascular research at the Charles University: the ‘PRAGUE’ trials and beyond (2020) (0)
Chapter 4 Diagnostic catheterization for pericardial, myocardial, and pulmonary diseases (2010) (0)
[Hypertrophic cardiomyopathy in old age]. (1988) (0)
Tilburg University The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures (2007) (0)
SMOKER↓S PARADOX IN CLOPIDOGREL EFFICACY? THE IMPACT OF SMOKING STATUS ON CLOPIDOGREL PRETREATMENT EFFICACY IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION (2008) (0)
[The ECG in prediction of the infarcted artery and left ventricular dysfunction]. (2002) (0)
Values of osteoprotegerin in aortic valve tissue differ significantly between calcified aortic valve stenosis and normal aortic valve and are influenced by the presence of coronary atherosclerosis (2013) (0)
Left Atrial Appendage Closure versus Non-Vitamin K Anticoagulants in High Risk Patients with Atrial Fibrillation: The PRAGUE-17 Trial (2019) (0)
Stroke thrombectomy (± thrombolysis), and not thrombolysis alone, should be the gold standard for stroke treatment. (2022) (0)
Acute stroke in a young healthy woman with hormonal contraception: Direct percutaneous thrombectomy with stent-retriever followed by full neurologic recovery (2013) (0)
Measuring of platelet activity and efficacy of antiplatelet therapy (2010) (0)
Preliminary clinical experience with intracoronary AlbunexR: a standardized echocontrast agent (1993) (0)
[Echocardiographical diagnosis of ruptures in mitral valve suspension apparatus (author's transl)]. (1981) (0)
[The Rotterdam Thoraxcentrum--the epitome of modern cardiology. II]. (1987) (0)
Chapter 7 PCI techniques (2010) (0)
Abstract 13554: Variations in MiRNAs Regulating Cardiac Growth are Not Common Cause of Hypertrophic Cardiomyopathy (2013) (0)
[Can ECG changes precede the development of myocardial hypertrophy in hypertrophic cardiomyopathy?]. (1988) (0)
Dose of aspirin does not inluence laboratory antiplatelet efficacy of P2Y12 inhibitors (2013) (0)
Chapter 5 Coronary angiography and other intracoronary diagnostic techniques (2010) (0)
Bioresorbable vascular scaffolds in STEMI patients: multimodality imaging comparison in mid-term perspective. (2016) (0)
[Does intracoronary thrombolytic therapy in myocardial infarct improve left ventricular function?]. (1985) (0)
Pacing of the interventricular septum with His bundle engagement, unlike myocardial pacings of the right ventricle, does not lead to ventricular dyssynchrony, as assessed by ultra-high frequency ECG (2020) (0)
Author`s Reply. (2021) (0)
[Are there abnormalities of parathormone, calcium and phosphorus metabolism in hypertrophic cardiomyopathy?]. (1990) (0)
[A ball-shaped thrombus with a thin stalk in the left atrium]. (1982) (0)
Mo-P2:204 The role of platelet activity in patients with patent versus occluded coronary artery bypass grafts. Prague-4 trial subanalysis (2006) (0)
(Is it time to replace acetylsalicylic acid monotherapy in secondary prevention with a more effective treatment?) (2022) (0)
[Autoantibodies in hypertrophic cardiomyopathy. II. Relation to the clinical manifestations of the disease]. (1987) (0)
[Left ventricular function in cardiogenic shock: is the size of the infarct more important or the kinetics of the "unaffected" heart muscle?]. (1986) (0)
Aspirin resistance after coronary artery bypass grafting (2010) (0)
Abstract 10358: Radial versus Femoral Approach in Non-ST Elevation ACS: Lessons From EARLY (2010) (0)
[Early diagnosis of acute myocardial infarction in two-dimensional echocardiography (author's transl)]. (1981) (0)
Abstract 180: Risks and Predictors of Ischemic/bleeding Complications in Cardiac Patients Undergoing Elective Non-cardiac Surgery - An Analysis of the Prague-14 Study (2015) (0)
[Echocardiography or ventriculography in ischemic heart disease?]. (1984) (0)
[Evaluation of infarct size using myocardial contrast echocardiography]. (1988) (0)
LONG-TERM OUTCOMES OF PATIENTS TREATED WITH ZOTAROLIMUS-ELUTING STENTS IN DIFFERENT INDICATIONS: ST ELEVATION MYOCARDIAL INFARCTION VERSUS ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION VERSUS STABLE ANGINA: A POOLED ANALYSIS FROM THE RESOLUTE PROGRAM (2012) (0)
Comprar Catheterization and Interventional Cardiology in Adult Patients | Petr Widimsky | 9780199558872 | Oxford University Press (2010) (0)
Obesity paradox in patients with acute heart failure:Application of propensity score methodology in an acute heartfailure database AHEAD (2012) (0)
Gender differences in cholesterol levels in patiens with acuteheart failure (2011) (0)
[Echocardiographic quantification of changes in left ventricular kinetics in patients during hospitalization for a first myocardial infarct and treated with direct angioplasty]. (2002) (0)
[Does verapamil affect the thickness of the cardiac muscle in hypertrophic cardiomyopathy?]. (1986) (0)
[Significance of 2-dimensional and Doppler echocardiography in the diagnosis of complications in myocardial infarct]. (1984) (0)
The European Society of Cardiology Stroke Council (2017) (0)
How many years it will take to implement the new stroke guidelines for the benefit of all suitable patients with acute ischemic stroke in Europe (2016) (0)
The importance of right bundle branch block in myocardial infarction (2009) (0)
POOLED ANALYSIS OF LONG–TERM SAFETY DATA FROM THE RESOLUTE CLINICAL TRIAL PROGRAM (2012) (0)
Patients transferred for primary PCI in APEX-AMI (Assessment of pexelizumab in acute myocardial infarction) trial have only modest symptom onset to PCI delays and good outcomes (2007) (0)
[Emergency myocardial revascularization during a developing myocardial infarct]. (1999) (0)
Widimsky myocardial infarction : an analysis from the TRITON-TIMI 38 trial Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation (2014) (0)
Classification and definition of acute coronary syndromes – A time for change? (2014) (0)
TCT-636 Final Three Year Results Following Resolute Zotarolimus-Eluting Stent Implantation in the RESOLUTE International Trial (2012) (0)
Ultrasound characteristics of myocardial hypertrophy in patients affected by hypertrophic cardiomyopathy. (1985) (0)
[Reversibility of asynergy in various forms of ischemic heart disease]. (1985) (0)
[Hypokinesis of the unaffected part of the left ventricle in cardiogenic shock--cause or result of shock?]. (1983) (0)
Prognosis of patients with mechanical ventilation in the acute phase of myocardial infarction in the era of primary coronary intervention (2007) (0)
The role of hypertension on short-term outcome of patientshospitalised for acute heart failure – cardiogenic shock (2012) (0)
[Can intracoronary thrombolytic therapy have an effect on the incidence of complications after myocardial infarct?]. (1986) (0)
Contents Vol. 102, 2004 (2004) (0)
P1727Prognosis predictors of patients with initial cardiogenic shock complicated acute myocardial infarction treated with primary angioplasty and intense antiplatelet therapy. PRAGUE-18 shock substudy (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Petr Widimský?

Petr Widimský is affiliated with the following schools: